Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Coeptis Therapeutics Holdings (COEPW) Receivables - Other (2023 - 2025)

Coeptis Therapeutics Holdings has reported Receivables - Other over the past 3 years, most recently at $1.6 million for Q4 2025.

  • Quarterly results put Receivables - Other at $1.6 million for Q4 2025, up 179.31% from a year ago — trailing twelve months through Dec 2025 was $4.6 million (changed N/A YoY), and the annual figure for FY2025 was $3.7 million, up 75.55%.
  • Receivables - Other for Q4 2025 was $1.6 million at Coeptis Therapeutics Holdings, down from $5.0 million in the prior quarter.
  • Over the last five years, Receivables - Other for COEPW hit a ceiling of $5.0 million in Q3 2025 and a floor of -$2.0 million in Q4 2024.
  • Median Receivables - Other over the past 3 years was $73779.5 (2023), compared with a mean of $789094.7.
  • Biggest five-year swings in Receivables - Other: crashed 5231.1% in 2024 and later soared 179.31% in 2025.
  • Coeptis Therapeutics Holdings' Receivables - Other stood at $38978.0 in 2023, then crashed by 5231.1% to -$2.0 million in 2024, then soared by 179.31% to $1.6 million in 2025.
  • The last three reported values for Receivables - Other were $1.6 million (Q4 2025), $5.0 million (Q3 2025), and -$2.0 million (Q4 2024) per Business Quant data.